Skip to main content

Allen Hubert L's Form 4 filing

Abbott Laboratories (ABT) · filed Jan 31, 2025

Accession no.
0001415889-25-002589
Filed
Jan 31, 2025
Trade date
Jan 29-30, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $24.3M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Allen Hubert LCIK 0001565916Officer (EXECUTIVE VICE PRESIDENT)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 29, 2025Common shares without par valueMOption exerciseAcquired+131,360$38.40+$5,044,224316,166Direct
Jan 29, 2025Common shares without par valueSSaleDisposed−131,360$128.35−$16,860,056184,806Direct
Jan 30, 2025Common shares without par valueMOption exerciseAcquired+58,428$38.40+$2,243,635.2243,234Direct
Jan 30, 2025Common shares without par valueSSaleDisposed−58,428$128.07−$7,482,873.96184,806Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 29, 2025Common sharesMOption exerciseDisposed−131,360$0.00$058,428Direct
Jan 30, 2025Common sharesMOption exerciseDisposed−58,428$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)